• Exchange: EN Brussels
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

RCUS:BB

32.7600 EUR 0.4600 1.42%

As of 11:35:00 ET on 12/19/2014.

Snapshot for Arseus NV (RCUS)

Open: 32.5000 Day's Range: 32.3750 - 33.1500 Volume: 104,512
Previous Close: 32.3000 52wk Range: 24.6300 - 44.9800 1-Yr Rtn: +22.19%

Stock Chart for RCUS

No chart data available.
  • RCUS:BB 32.7600
  • 1D
  • 1M
  • 1Y
32.3000
Interactive RCUS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RCUS

Current P/E Ratio (ttm) 20.2721
Estimated P/E(12/2014) 17.7081
Relative P/E vs. BEL20 0.5121
Earnings Per Share (EUR) (ttm) 1.6160
Est. EPS (EUR) (12/2014) 1.8500
Est. PEG Ratio -
Market Cap (M EUR) 1,029.69
Shares Outstanding (M) 31.43
30 Day Average Volume 119,165
Price/Book (mrq) 6.8444
Price/Sale (ttm) 3.2092
Dividend Indicated Gross Yield 2.20%
Cash Dividend (EUR) 0.5400
Dividend Ex-Date 05/14/2014
5 Year Dividend Growth 19.14%
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RCUS

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for RCUS

Arseus NV provides a wide range of products for the health, wellness, esthetics and ageing populations. The Company distributes and resells dental equipment, medical equipment, pharmaceuticals, and provides integrated information technology solutions for healthcare professionals.

Gerardus Van Jeveren "Ger"Chief Executive OfficerJan PeetersChief Financial Officer
Dirk Van LerbergheCEO:CorilusMario HuygheCEO:Healthcare Solutions
More Company Profile & Key Executives for RCUS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil